We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PARR:NYSEPar Pacific Holdings, Inc. Common Stock Analysis

Data as of 2026-05-26 - not real-time

$58.83

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Par Pacific (PARR) is trading at $58.83, comfortably above its 20‑day SMA of 62.72 but still below the short‑term average, and the RSI sits at 44.5 indicating neutral momentum. The MACD histogram is negative and the signal line is bullish, suggesting short‑term pressure despite an overall bullish trend direction. The company posted a record Q1 conventional refining throughput of 184,000 bpd, driven by strong performance in Hawaii and Montana, which bolsters its operating cash flow of $406 M. Fundamentals are attractive: a trailing P/E of 6.66 versus an industry average of 21.6, a price‑to‑book of 1.93, and an ROE of 33.3% highlight efficient capital use. The DCF‑derived fair value of $13.68 is far below the market price, but the model’s upside/downside metric shows a 22% upside potential, reflecting market mispricing. Debt remains moderate with a debt‑to‑equity of 87.5% and ample cash of $172 M, while free cash flow of $118 M supports ongoing operations. With a 30‑day volatility of 65% and a beta of –0.26, the stock is volatile yet exhibits low market correlation, and the “Extreme Greed” sentiment index (91.46) underscores strong investor appetite.
Given the low valuation multiples, solid cash generation, and record refining performance, the stock appears undervalued on a value basis, though short‑term technical weakness and sector cyclicality temper enthusiasm. The energy‑refining sector carries medium‑to‑high regulatory and commodity‑price risk, but PARR’s diversified geographic footprint across the U.S. mitigates concentration risk. Overall, the balance of quantitative metrics and recent operational highlights supports a cautious buy stance for medium‑ to long‑term horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram and price below 20‑day SMA
  • Neutral RSI indicating limited upside momentum
  • High 30‑day volatility (65%) raising near‑term price swings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Low trailing P/E (6.66) vs industry average (21.6)
  • Record refining throughput and strong operating cash flow
  • Upside potential of ~22% based on valuation metrics

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust ROE (33.3%) and solid balance sheet with manageable debt
  • Diversified U.S. geographic footprint reducing location risk
  • Value‑oriented valuation with price‑to‑book under 2 and low price‑to‑sales

Key Metrics & Analysis

Financial Health

Revenue Growth4.50%
Profit Margin6.02%
P/E Ratio6.7
ROE33.32%
ROA9.42%
Debt/Equity87.47
P/B Ratio1.9
Op. Cash Flow$406.0M
Free Cash Flow$118.5M
Industry P/E21.6

Technical Analysis

TrendBullish
RSI44.5
Support$56.04
Resistance$70.39
MA 20$62.72
MA 50$61.80
MA 200$44.24
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair Value$13.68
Target Price$72.00
Upside/Downside22.39%
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.26
Volatility65.06%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.